You have skipped the navigation, tab for page content
Maxigesic becomes latest new sponsorship partner

Leading Kiwi pain relief brand Maxigesic® has signed up with the One New Zealand Warriors for the 2024 and 2025 seasons.

The Maxigesic® name will feature on the front of the playing shorts for all five of the club’s teams this season in the NRL, New South Wales Cup, Jersey Flegg Cup (under-21), SG Ball Cup (under-19) and Harold Matthews Cup (under-17).

As the club’s official pain relief partner, Maxigesic® will also be the presenting partner for a ‘Big Hit of the Week’ video feature as well as the weekly recovery report.

“We’ve come off a watershed season in 2023 but 2024 is even bigger for us as we field an unprecedented five teams across various competitions,” said One New Zealand Warriors general manager commercial and consumer business Glenn Critchley.

“So partnering with an innovative brand leader like Maxigesic® is critical. We’re thrilled to have them on board.”

Developed and marketed by Takapuna-based AFT Pharmaceuticals, the patented Maxigesic® combination of Paracetamol and Ibuprofen is now sold in more than 60 countries worldwide.

“We’re very excited to have Maxigesic® partner with the One New Zealand Warriors family and form a perfect combination for the next two seasons,” said Hartley Atkinson, chief executive of AFT Pharmaceuticals and inventor of Maxigesic®. 

“We feel a real affinity with the One New Zealand Warriors and their journey. Having initially developed and launched Maxigesic® at home in New Zealand, we’ve taken on the Australian market and established Maxigesic® as the number one selling Paracetamol/Ibuprofen combination* on the other side of the Tasman, so we’re fully supportive of the One New Zealand Warriors achieving their own historic milestone of winning a first NRL title.

“By bringing Maxigesic® and the One New Zealand Warriors together, we’re confident that we Kiwis are going to fly, both at home and away, in the 2024 season.”

Maxigesic® was developed as a smarter alternative that provides faster and more effective pain relief than other analgesics, particularly those containing opioids, and is clinically proven to provide 78 per cent more effective pain relief than Paracetamol alone and 36 per cent more effective pain relief than Ibuprofen alone¹.

  • Ref. 1: Two tablets of MAXIGESIC® four times per day provides more effective pain relief than a full daily dose of Paracetamol or Ibuprofen given in four divided doses. Claim based on trials of postoperative pain relief after removal of 1–4 wisdom teeth. Daniels et al (2018). Research sponsored by AFT Pharmaceuticals.
  • Do not use if you have a stomach ulcer. Always read the label. Use only as directed. Incorrect use can be harmful. If symptoms persist consult your healthcare professional. AFT Pharmaceuticals, Auckland. Patent No. 552181.
  • Source: Circana Total Australian Pharmacy sales data – MAT unit and dollar sales to 17/12/23
Acknowledgement of Country

The New Zealand Warriors honour the mana of the Indigenous peoples of Aotearoa, Australia and the Pacific. We acknowledge the traditional kaitiaki of the lands, elders past and present, their stories, their traditions, their mamae and their mana motuhake.

Principal Partner

Major Partners

Official Sponsors

View All Partners